Wageningen Bioveterinary Research and Ceva form strategic alliance to counter global threat of emerging and re-emerging diseases
Wageningen Bioveterinary Research (WBVR) and Ceva Santé Animale (Ceva) announced a new collaboration to develop veterinary vaccines for the control of (re)emerging infectious animal diseases, such as Rift Valley fever and Influenza.
6 June 2018
2 minute read
